Globalization has many advantages. Products and services are available around the world. At the same time, standards have to be harmonized in order to ensure uniform quality and safety parameters. One particularly sensitive area is drug safety.

A major issue in the patient protection worldwide

The DiapharmGroup is an alliance of consulting and service companies who are active in the pharmaceutical and health products industry. The Zentralinstitut Arzneimittelforschung GmbH (Central Institute for Drug Research) is the service laboratory of the DiapharmGroup and is responsible for quality control of its products. It is certified in accordance with Good Manufacturing Practice (GMP) and is authorized to approve drugs for the market pursuant to the German Drug Law.

Read the whole Case Study here